BMI View: Algeria's large and growing healthcare and pharmaceutical market will continue to drive
interest from multinational drugmakers over the forecast period. Meanwhile, Algeria's pharmaceutical
exports will continue to expand as the country gradually strengthens ..."
BMI View: The Algerian pharmaceutical market will remain attractive to multinational drugmakers,
despite the slow pace of improvements in the regulatory and market access environment. Key market
drivers such as growing demand for healthcare, rising chronic disease bur ..."
BMI View: Despite a slowdown in the Algerian economy due to low oil prices, the country's
pharmaceutical and healthcare markets are expected to sustain their positive growth trajectory over a
multi-quarter horizon. The health sector expansion will be supported by long ..."
BMI View: While the effects of the global oil price slump will slowdown Algeria's public and private
spending growth rates over a multi-quarter horizon, the government will keep the modernisation of
healthcare facilities and the expansion of drug manufacturing capacit ..."
BMI View: Long-term growth prospects in Algeria's pharmaceutical and healthcare sector will continue to
generate investment opportunities to foreign firms, including in the development of drug manufacturing
capacity and technology transfer with joint partnerships with ..."
BMI View: The Algerian government's five-year investment and industrial development plan to be
implemented from 2015-2019 will provide opportunities to foreign drugmakers looking to enter the
Algerian pharmaceutical market or to expand their operations in the region t ..."
BMI View: Against a backdrop of economic growth, the Algerian government commitment to expand and
upgrade medical coverage and healthcare services in Algeria will translate in growing commercial
opportunities for pharmaceutical and healthcare industries over the mediu ..."
BMI View: The Algerian government's aspirations to rebalance the pharmaceutical trade deficit and
promote local generic production, whilst enhancing the country's competitiveness by stimulating the
innovative biopharmaceutical industry as a strategic sector in the eco ..."
BMI View: The major developments this quarter were local drugmaker Saidal's two licensing
manufacturing agreements with foreign drugmakers, and the Algerian College of Cardiologists' call for
new hypertension medicines, which illustrates growing interest in the market ..."
BMI View: Though we caution that operational risks in Algeria will remain elevated, the market is not only
one of the largest in Africa, but also highly import-reliant, and thus of considerable interest of companies
looking for new revenue sources. Government programm ..."